Cardiac Wire #151 February 12, 2024
Bypass Surgery’s Hypertension Impact | Too Big for Donor Hearts
Cardiac Wire #150 February 8, 2024
Biosense Webster’s PFA Evidence | Zepbound’s Boundless Potential
Cardiac Wire #149 February 5, 2024
First TR Treatment | HCM’s TV Moment
Cardiac Wire #148 February 1, 2024
SAVR’s Outcomes vs. TAVR Adoption | Heart Disease Unawareness
Cardiac Wire #147 January 29, 2024
Vascepa’s ACS Advantage | Stopping the Bleed
Cardiac Wire #146 January 25, 2024
Smartphone CVD Detection | Sitting’s Cardiovascular Risks
Cardiac Wire #145 January 22, 2024
Lipoprotein(a)’s Per-Particle Risks | PFA Haemolysis
Cardiac Wire #144 January 18, 2024
Private Equity’s Cardiology Impact | Echo AI for RHD
Cardiac Wire #143 January 11, 2024
Faster Heart Failure GDMT Optimization | Cleerly ISCHEMIA
Cardiac Wire #142 January 8, 2024
Applied AT-001’s Phase 3 Miss | Lilly Does DTC
Cardiac Wire #141 January 4, 2024
Aficamten’s Striking Results | AED Bystander Effect
Cardiac Wire #140 December 18, 2023
The US’ First PFA System | Cholesterol Vaccine on the Horizon
Cardiac Wire #139 December 14, 2023
Ultrasound-Guided Cath Labs | 2023 CVD Almanac
Cardiac Wire #138 December 11, 2023
Echo AI Strain Validation | BP Drug Parity
Cardiac Wire #137 December 7, 2023
Roche Enters Obesity Arena | Statin Underuse
Cardiac Wire #136 December 4, 2023
LAA Competitor Surge | New AFib Guidelines
Cardiac Wire #135 November 30, 2023
The Best in Cardiology News | Saving Rural Cardiology
Cardiac Wire #134 November 27, 2023
A Factor XI Setback | Us2.ai’s Echo Strain Accuracy
Cardiac Wire #133 November 20, 2023
